Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

(Form Type)

 

Alzamend Neuro, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

  Table 1 – Newly Registered Securities
  Security
Type (1)
Security Class Title Fee
Calculation
Rule
Amount
Registered
Proposed
Maximum
Offering Price
Per Unit
Maximum
Aggregate
Offering Price
Fee
Rate
Amount of
Registration
Fee
Carry
Forward
Form Type
Carry
Forward
File
Number
Carry
Forward
Initial
Effective
Date
Filing Fee
Previously
Paid in
Connection
with Unsold
Securities to
be Carried
Forward
Fees to Be Paid Equity Common stock, par value $0.001 per share
Fees to Be Paid Equity Preferred stock, par value $0.001 per share
Fees to Be Paid Other Warrants (3)
Fees to Be Paid Other Rights (4)
Fees to Be Paid Other Units (5)
Fees to Be Paid Unallocated (Universal) Shelf Rule 457(o) (2) (2) $25,000,000 $0.0001102 $2,755.00
  Table 2 – Carry Forward Securities
Carry Forward Securities
  Total Offering Amounts
  Total Fees Previously Paid
  Total Fee Offsets
  Net Fee Due

 

  (1) There are being registered hereunder such indeterminate amount of the securities of each identified class as may from time to time be offered hereunder by the Registrant at indeterminate prices which shall have an aggregate initial offering price not to exceed $25,000,000. The securities being registered hereunder also include such indeterminate amount of securities as may be issued upon exercise, settlement, exchange or conversion securities offered or sold hereunder, or pursuant to the anti-dilution provisions of any such securities.
  (2) The proposed maximum offering price per security for the primary offering will be determined, from time to time, by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act.
  (3) Warrants may represent rights to purchase common stock, preferred stock or other securities registered hereunder.
  (4) Rights evidence rights to purchase any securities of the Registrant registered under this registration statement.
  (5) Any securities registered under this registration statement may be sold separately or as units with other securities registered under this registration statement.

 

 

1